Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N

Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N

US Patent 10653743 · Granted May 19, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conjugation of MCR1 ligand with cytotoxic drugs for treating skin cancer2025
Melanocortin 1 receptor ligands and methods of use2024
Neuroprotective beta amyloid core peptides and peptidomimetic derivatives2024
Modulators of melanocortin receptors for the treatment of depression and anxiety2023
Modulators of melanocortin receptors for the treatment of depression and anxiety2023
Modulators of melanocortin receptors for the treatment of depression and anxiety2023
Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing2022
Melanocortin 1 receptor ligands and methods of use2022
Bifunctional compounds for relief of pain comprising an opioid receptor agonist 2021
Modulators of melanocortin receptors2021
Modulators of melanocortin receptors2021
Opioid receptor modulators2020